COVID-19大流行对年龄≥67岁糖尿病 Medicare 按服务付费受益者医疗支出的影响
研究基于100% Medicare按服务付费理赔数据,比较COVID-19前(2019年3月至2020年2月)与COVID-19期间(2020年3月至2022年2月)糖尿病受益人的总医疗支出和自付支出。至第二流行年第四季人均支出回升至6096美元,超过大流行前同季的5982美元。大流行期间人群和人均自付支出均低于大流行前。
要点
- 大流行第一季人均总支出降至5356美元,第二流行年第四季回升至6096美元,超过大流行前同季的5982美元。
- 大流行期间人群和人均自付支出均低于大流行前。
核心结论
- COVID-19对糖尿病 Medicare 受益人的总医疗支出和人均医疗支出均有显著影响。
- COVID-19大流行与较低的自付支出相关。
研究设计与样本
- 数据来自100% Medicare按服务付费理赔数据,糖尿病通过ICD-10编码识别。
- 比较COVID-19前(2019年3月至2020年2月)与COVID-19期间(2020年3月至2022年2月)的总医疗支出和自付支出。
- 按季度计算人群水平和人均水平的总支出及自付支出,并按服务类型分层。
- 人均支出为同一季度人群支出除以该季度糖尿病受益人数。
- 支出变化为大流行前年份与大流行年份相同季度之间的差值。
主要发现
- 大流行第一季人均总支出从大流行前同季的6500美元降至5356美元,至第二流行年第四季升至6096美元,超过大流行前同季的5982美元。
- 大流行期间人群和人均自付支出均低于大流行前。
- 大流行前与COVID-19期间人均支出按服务类型的变化各不相同。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To compare total and out-of-pocket (OOP) medical expenditures between pre-COVID-19 (March 2019 to February 2020) and COVID-19 (March 2020 to February 2022) periods among Medicare beneficiaries with diabetes. RESEARCH DESIGN AND METHODS: Data were from 100% Medicare fee-for-service claims. Diabetes was identified using ICD-10 codes. We calculated quarterly total and OOP medical expenditures at the population and per capita level in total and by service type. Per capita expenditures were calculated by dividing the population expenditure by the number of beneficiaries with diabetes in the same quarter. Changes in expenditures were calculated as the differences in the same quarters between the prepandemic and pandemic years. RESULTS: Population total expenditure fell to $33.6 billion in the 1st quarter of the pandemic from $41.7 billion in the same prepandemic quarter; it then bounced back to $36.8 billion by the 4th quarter of the 2nd pandemic year. The per capita total expenditure fell to $5,356 in the 1st quarter of the pandemic from $6,500 in the same prepandemic quarter. It then increased to $6,096 by the 4th quarter of the 2nd pandemic year, surpassing the same quarter in the prepandemic year ($5,982). Both population and per capita OOP expenditures during the pandemic period were lower than the prepandemic period. Changes in per capita expenditure between the pre-COVID-19 and COVID-19 periods by service type varied. CONCLUSIONS: COVID-19 had a significant impact on both total and per capita medical expenditures among Medicare beneficiaries with diabetes. The COVID-19 pandemic was associated with lower OOP expenditures.
引用
- Wang Y, Zhang P, Zhou X, et al. Impact of the COVID-19 Pandemic on Medical Expenditures Among Medicare Fee-for-Service Beneficiaries Aged ≥67 Years With Diabetes. Diabetes Care. 2024. PMID: 38227901. doi:10.2337/dc23-1679
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。